SFDA Speeds Up Release Of Vaccines To Quake-Hit Regions
This article was originally published in PharmAsia News
Executive Summary
Due to the urgent needs of earthquake victims, China's State FDA has, for the second time, adjusted the procedure for release of blood products and vaccines to speed up the distribution of relief supplies. SFDA and vaccine manufacturers will synchronize the quality inspection and approval of badly needed vaccine and blood products that have been produced but are awaiting approval, as well as products still being churned out. These include tetanus immunoglobulin, human albumin, cholera toxin B subunit vaccine, hepatitis A vaccine, Japanese B encephalitis vaccine, diphtheria and tetanus combined vaccine, tetanus vaccine and hemorrhagic fever vaccine. (Click here for more - Chinese Language)